Who is sponsoring NCT06335420?

NCT06335420 is sponsored by Odense University Hospital.

What drugs are being tested in NCT06335420?

Interventions in NCT06335420: Carrot juice from Yellowstone carrots cultivars, Placebo juice.

What condition does NCT06335420 study?

NCT06335420 studies Colorectal Cancer Prevention.

Is NCT06335420 still recruiting?

NCT06335420 is currently recruiting now. Last updated 20 November 2025.

Last reviewed 2025-11-20 · How we verify

NCT06335420: Px7

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prophylactic Properties of Carrot Juice in Patients With High-Risk Colorectal Polyps

Recruiting now NA Last updated 20 November 2025

What this trial tests

NA trial testing Carrot juice from Yellowstone carrots cultivars in Colorectal Cancer Prevention in 400 participants. Currently enrolling.

Timeline

20 June 2024

Primary endpoint
1 June 2027

1 December 2027

Quick facts

Lead sponsor	Odense University Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	400
Start date	20 June 2024
Primary completion	1 June 2027
Estimated completion	1 December 2027
Sites	1 location across Denmark

Drugs / interventions tested

Carrot juice from Yellowstone carrots cultivars
Placebo juice — full drug profile →

Conditions studied

Colorectal Cancer Prevention — all drugs for Colorectal Cancer Prevention →

Sponsor

Odense University Hospital

Who can join

18 and older, any sex, with Colorectal Cancer Prevention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this prospective randomized double-blinded bi-national study is to test the prophylactic effect of polyacetylenes from carrots on the population of patients who had a resection of high-risk adenomas of the large bowel. The main question it aims to answer is: Will carrot juice rich in polyacetylenes inhibit neoplastic transformation and growth in high-risk humans? Participants will have to drink 100 ml of juice daily after the adenoma resection for 1 year and keep a simple diary/calendar. Researchers will compare the group with ingestion of Falcarinol (FaOH) / Falcarindiol (FaDOH) rich carrot juice versus the group consuming placebo juice, to see if the polyacetylenes significantly reduces neoplastic transformation and growth in high-risk patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Polyp prophylactic properties of polyacetylenes from carrots in patients with previous polypectomy-Px7 The study protocol of a multicentre binational randomised controlled trial.
Agache A, Deding U, Kaalby L, Kobaek-Larsen M, et al · · 2025 · PMID 41314836 · DOI 10.1136/bmjopen-2024-095376

Verify or expand the search:

Other recruiting trials for Colorectal Cancer Prevention

Currently open trials in the same condition.

NCT07095517 — Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors · Phase 1 · recruiting
NCT07086833 — The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities · NA · recruiting
NCT02843425 — The Beans to Enrich the Gut Microbiome vs. Obesity's Negative Effects (BE GONE) Trial · NA · active not recruiting

Other Odense University Hospital trials

Trials by the same sponsor.

NCT07163091 — Bracing After Ankle Fracture · NA · not yet recruiting
NCT07521696 — Physical Recovery During Bracing After Ankle Fracture (Re-BAF) · NA · not yet recruiting
NCT07466212 — QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy · not yet recruiting
NCT07191379 — Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma · Phase 4 · not yet recruiting
NCT07170085 — Positioning of Children With Acute Respiratory Insufficiency · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06335420 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Odense University Hospital
Last refreshed: 20 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06335420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing